MedTrace Logo

Comparison Study Between Cefdinir & Amoxicilline/Clavulanate in Acute Sinusitis and Assessment of Quality of Life

NCT00147914 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-05-02

No results posted yet for this study

Summary

This study is a comparison between two commonly used antibiotics (Cefdinir vs. Amoxicillin/Clavulanate) in patients with acute sinus infection, surveying quality of life. The hypothesis is that the two treatments would be at the least equivalent based on clinical outcome measures of improvement in quality of life.

Conditions

  • Acute Bacterial Sinusitis

Interventions

DRUG

Cefdinir (drug)

cefdinir 300mg per orally twice daily for 10 days

DRUG

amoxicillin/clavulanate

1000mg /62.5mg extended release per orally twice daily for 10 days

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Jacquelynne Corey, M.D. · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2007-02-28
Completion
2017-02-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00147914 on ClinicalTrials.gov